(S (S (NP-SBJ (NN Calcineurin)) (VP (VBZ potentiates) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor) (NN gene))) (PP (IN in) (NP (NN T) (NNS cells))))) (: :)) (NP (NP (NN involvement)) (PP (IN of) (NP (DT the) (VBN conserved) (NN lymphokine) (NN element) (CD 0))) (. .)))
(S (NP-SBJ-COOD-15 (NP (NP (JJ Granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (CC and) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-)))) (VP (VBP are) (VP (VBN produced) (NP (-NONE- *-15)) (PP (IN by) (NP (NP (NN stimulation)) (PP (IN with) (NP-COOD (NP (NP (NN phorbol-12-myristate) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN calcium) (NN ionophore)) (PRN (-LRB- -LRB-) (NP (NN A23187)) (-RRB- -RRB-))))) (PP (IN in) (NP (JJ human) (NN T) (NN cell) (NN leukemia) (NN Jurkat) (NNS cells))))))) (. .))
(S (NP-SBJ-16 (NP (DT The) (NN expression)) (PP (IN of) (NP-COOD (NP (NN GM-CSF)) (CC and) (NP (NN IL-2))))) (VP (VBZ is) (VP (VBN inhibited) (NP (-NONE- *-16)) (PP (IN by) (NP-LGS (NP (JJ immunosuppressive) (NNS drugs)) (PP (JJ such) (IN as) (NP-COOD (NP (NP (NN cyclosporin) (NN A)) (PRN (-LRB- -LRB-) (NP (NN CsA)) (-RRB- -RRB-))) (CC and) (NP (NN FK506)))))))) (. .))
(S (NP-SBJ (NP (JJR Earlier) (NNS studies)) (PP (IN on) (NP (DT the) (NN IL-2) (NN gene) (NN expression)))) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (NP (NN overexpression)) (PP (IN of) (NP (NP (NP (NN calcineurin)) (PRN (-LRB- -LRB-) (NP (NN CN)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ (calmodulin-dependent Ca2+)) (NN protein) (NN phosphatase)) (, ,)))) (VP (MD can) (VP (VB stimulate) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN IL-2) (NN promoter)))) (PP (IN through) (NP (DT the) (JJ NF-AT-binding) (NN site)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBD obtained) (NP (NN evidence) (SBAR (IN that) (S (NP-SBJ (NP (NN transfection)) (PP (IN of) (NP (NP (DT the) (NNS cDNAs)) (PP (IN for) (NP (NP-COOD (NP (NP (NN CN) (NN A)) (PRN (-LRB- -LRB-) (ADJP (JJ catalytic)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CN) (NN B)) (PRN (-LRB- -LRB-) (ADJP (JJ regulatory)) (-RRB- -RRB-)))) (NNS subunits)))))) (ADVP (RB also)) (VP-COOD (VP (VBZ augments) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN GM-CSF) (NN promoter))))) (CC and) (VP (VBZ recovers) (NP (NP (DT the) (NN transcription)) (VP (VBN inhibited) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NN CsA))))))))))) (. .))
(S (NP-SBJ-17 (NP (DT The) (ADJP (RB constitutively) (JJ active)) (NN type)) (PP (IN of) (NP (DT the) (NN CN) (NN A) (NN subunit))) (, ,) (SBAR (WHNP-18 (WDT which)) (S (NP-SBJ (-NONE- *T*-18)) (VP (VBZ lacks) (NP (DT the) (ADJP-COOD (ADJP (JJ auto-inhibitory)) (CC and) (ADJP (JJ calmodulin-binding))) (NNS domains))))) (, ,)) (VP (VBZ acts) (PP (IN in) (NP (NP (NN synergy)) (PP (IN with) (NP (NN PMA))))) (S (NP-SBJ (-NONE- *-17)) (VP (TO to) (VP (VB activate) (NP (NP (NN transcription)) (PP (IN from) (NP (DT the) (NN GM-CSF) (NN promoter)))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ-19 (DT the) (JJ active) (NN CN)) (ADVP (RB partially)) (VP (VBZ replaces) (NP (NN calcium) (NN ionophore)) (PP (IN in) (NP (NP (NN synergy)) (PP (IN with) (NP (NN PMA))))) (S (NP-SBJ (-NONE- *-19)) (VP (TO to) (VP (VB induce) (NP (NP (NN expression)) (PP (IN of) (NP (JJ endogenous) (NP-COOD (NP (NN GM-CSF)) (CC and) (NP (NN IL-2))))))))))))) (. .))
(S (PP (IN By) (S (NP-SBJ (-NONE- *-20)) (VP (VBG multimerizing) (NP (NP (DT the) (JJ regulatory) (NNS elements)) (PP (IN of) (NP (DT the) (NN GM-CSF) (NN promoter))))))) (, ,) (NP-SBJ-20 (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP-SBJ (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NN target) (NNS sites)) (PP (IN for) (NP (DT the) (NN CN) (NN action)))))) (VP (VBZ is) (NP-PRD (NP (NP (DT the) (VBN conserved) (NN lymphokine) (NN element) (CD 0)) (PRN (-LRB- -LRB-) (NP (NN CLE0)) (-RRB- -RRB-))) (, ,) (ADJP (JJ located) (PP (IN at) (NP (NP (NNS positions)) (PP (IN between) (NP-COOD (NP (CD -54)) (CC and) (NP (CD -40)))))))))))) (. .))
(S (NP-SBJ (NN Mobility) (NN shift) (NNS assays)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-21 (DT the) (NN CLE0) (NN sequence)) (VP-COOD (VP (VBZ has) (NP (DT an) (JJ AP1-binding) (NN site))) (CC and) (VP (VBZ is) (VP (VBN associated) (NP (-NONE- *-21)) (PP (IN with) (NP (NP (DT an) (JJ NF-AT-like) (NN factor)) (, ,) (VP (VBN termed) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN NF-CLE0) (NN gamma)))))))))))) (. .))
(S (NP-SBJ-22 (NN NF-CLE0) (NN gamma) (NN binding)) (VP-COOD (VP (VBZ is) (VP (VBN induced) (NP (-NONE- *-22)) (PP (IN by) (NP-LGS (NN (A23187 PMA)))))) (CC and) (VP (VBZ is) (VP (VBN inhibited) (NP (-NONE- *-22)) (PP (IN by) (NP-LGS (NP (NN treatment)) (PP (IN with) (NP (NN CsA)))))))) (. .))
(S (NP-SBJ (DT These) (NNS results)) (VP (VBP suggest) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ-24 (NN CN)) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-24)) (PP (IN in) (NP (NP (DT the) (VBN coordinated) (NN induction)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NN GM-CSF)) (CC and) (NP (NN IL-2))) (NNS genes))))))))) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN CLE0) (NN sequence)) (PP (IN of) (NP (DT the) (NN GM-CSF) (NN gene)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ functional) (NN analogue)) (PP (IN of) (NP (NP (DT the) (JJ NF-AT-binding) (NN site)) (PP (IN in) (NP (DT the) (NN IL-2) (NN promoter))))) (, ,) (SBAR (WHNP-25 (WDT which)) (S (NP-SBJ (-NONE- *T*-25)) (VP (VBZ mediates) (NP (NP (NNS signals)) (ADJP (RB downstream) (PP (IN of) (NP (NN T) (NN cell) (NN activation)))))))))))))) (. .))
